AMENDMENT TO SECURITIES PURCHASE AGREEMENTSSecurities Purchase Agreements • August 18th, 2020 • Delcath Systems, Inc. • Surgical & medical instruments & apparatus
This Amendment (the “Amendment”), dated as of August 18, 2020, is made to (i) that certain Securities Purchase Agreement (the “Series E Purchase Agreement”), dated as of July 11, 2019, and (ii) that certain Securities Purchase Agreement (the “Series E-1 Purchase Agreement,” together with the Series E Purchase Agreement, the “Purchase Agreements”), dated as of August 15, 2019, each between Delcath Systems, Inc. (the “Company”) and the purchasers signatories thereto. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Purchase Agreements.
AMENDMENT TO SECURITIES PURCHASE AGREEMENTSSecurities Purchase Agreements • November 5th, 2010 • Marina Biotech, Inc. • Pharmaceutical preparations • New York
THIS AMENDMENT to: (i) that certain Securities Purchase Agreement dated as of April 25, 2008 between Marina Biotech, Inc., a Delaware corporation (the “Company”), and the purchasers identified on the signature pages thereto (the “April 2008 SPA”); (ii) that certain Securities Purchase Agreement dated as of June 9, 2009 between the Company and the purchasers identified on the signature pages thereto (the “June 2009 SPA”); and (iii) that certain Securities Purchase Agreement dated as of January 13, 2010 between the Company and the purchasers identified on the signature pages thereto (the “January 2010 SPA” and, together with the April 2008 SPA and the June 2009 SPA, the “Purchase Agreements”), is dated as of November 4, 2010.
OMNIBUS AMENDMENT TO SECURITIES PURCHASE AGREEMENTSSecurities Purchase Agreements • February 24th, 2023 • Vallon Pharmaceuticals, Inc. • Pharmaceutical preparations
This Omnibus Amendment to Securities Purchase Agreements, dated as of February 17, 2023 (this “Amendment”), is entered into by and among GRI Bio, Inc., a Delaware corporation (the “PrivateCo”), Vallon Pharmaceuticals, Inc., a Delaware corporation (“PubCo”), and Altium Growth Funds, LP, a New York limited partnership (the “Buyer”) (each a “Party” and collectively, the “Parties”).
Exhibit 10-J AMENDMENT TO THE SECURITIES PURCHASE AGREEMENTS This Amendment No. 1 to the Securities Purchase Agreement dated June 21, 2002 (the "June Agreement") by and among Infinite Group, Inc., a Delaware corporation (the "Company"), and Laurus...Securities Purchase Agreements • August 28th, 2002 • Infinite Group Inc • Miscellaneous electrical machinery, equipment & supplies
IRREVOCABLE WAIVER AND AMENDMENT TO SECURITIES PURCHASE AGREEMENTSSecurities Purchase Agreements • December 5th, 2017 • Cue Biopharma, Inc. • Pharmaceutical preparations • Delaware
THIS IRREVOCABLE WAIVER AND AMENDMENT TO SECURITIES PURCHASE AGREEMENTS (this “Amendment”) is made and entered into this as of November __, 2017, by and among Cue Biopharma, Inc., a Delaware corporation (the “Company”), and the Purchasers (as defined in the Recitals below). Capitalized terms used but not defined herein shall have the meanings set forth in the Agreement (defined in the Recitals below).
AMENDMENT TO SECURITIES PURCHASE AGREEMENTSSecurities Purchase Agreements • April 14th, 2022 • Gaming Technologies, Inc. • Services-prepackaged software
This Amendment to Securities Purchase Agreements (this “Amendment”) is dated as of April 6, 2022, between Gaming Technologies, Inc. (f.k.a. Dito, Inc.), a Delaware corporation (the “Company”), and _________________________ (the “Purchaser”).
AMENDMENT TO SECURITIES PURCHASE AGREEMENTSSecurities Purchase Agreements • May 4th, 2022 • Gaming Technologies, Inc. • Services-prepackaged software
This Amendment to Securities Purchase Agreements (this “Amendment”) is dated as of April 26, 2022, between Gaming Technologies, Inc., a Delaware corporation (the “Company”), and ____________________ (the “Purchaser”).
